Cargando…
Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits
INTRODUCTION: Expanded access is the use of an investigational product by patients with serious medical conditions without participation in a clinical trial. It is a complicated process involving the collaboration of many parties and pharmaceutical companies. Ongoing efforts focus on accelerating ex...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291242/ https://www.ncbi.nlm.nih.gov/pubmed/29353505 http://dx.doi.org/10.1080/13543784.2018.1430137 |